CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease-The ENCORE Trials

Atherosclerosis

Volumn 207, Issue 2, 2009, Pages 476-479

  Hermann, M ^a   Hellermann, J P ^a   Quitzau, K ^a   Hoffmann, M M ^b   Gasser, T ^c   Meinertz, T ^d   Munzel T ^e   Fleming, I ^f   Luscher T F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^f GOETHE UNIVERSITY   (Germany)

Author keywords

Coronary artery disease; Cytochome p450; Endothelial function; Hypertension; Polymorphism

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; CYSTEINE; CYTOCHROME P450 2C9; CYTOCHROME P450 2J2; CYTOCHROME P450 4A11; GLYCINE; GUANOSINE; ISOLEUCINE; LEUCINE; PHENYLALANINE; SERINE; THYMIDINE;

ADULT; AMINO ACID SUBSTITUTION; ARTERY ENDOTHELIUM; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROMOTER REGION; SYSTOLIC BLOOD PRESSURE; VASOMOTOR REFLEX;

ACETYLCHOLINE; AGED; ARYL HYDROCARBON HYDROXYLASES; BIOLOGICAL MARKERS; BLOOD PRESSURE; CLINICAL TRIALS AS TOPIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; CREATININE; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; VASOCONSTRICTION;

EID: 70549112238     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.06.009     Document Type: Article

References (14)

1. Ludmer P.L., Selwyn A.P., Shook T.L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315 (1986) 1046-1051
2. Schachinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
3. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes Jr. D.R., and Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 (2000) 948-954
4. Fleming I. Epoxyeicosatrienoic acids, cell signaling and angiogenesis. Prostaglandins Other Lipid Mediat 82 (2007) 60-67
5. Gainer J.V., Bellamine A., Dawson E.P., et al. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 111 (2005) 63-69
6. Mayer B., Lieb W., Gotz A., et al. Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy. Hypertension 46 (2005) 766-771
7. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function). Circulation 107 (2003) 422-428
8. Mayer B., Lieb W., Gotz A., et al. Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction. J Hypertens 24 (2006) 1965-1970
9. Luscher T.F., Richard V., Tschudi M., Yang Z.H., and Boulanger C. Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol 15 (1990) 519-527
10. Imig J.D., Zou A.P., Stec D.E., Harder D.R., Falck J.R., and Roman R.J. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol 270 (1996) R217-R227
11. Ma Y.H., Gebremedhin D., Schwartzman M.L., et al. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72 (1993) 126-136
12. Ward N.C., Rivera J., Hodgson J., et al. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. Circulation 110 (2004) 438-443
13. Spieker L.E., Sudano I., Hurlimann D., et al. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 105 (2002) 1399-1402
14. Sugimoto K., Akasaka H., Katsuya T., et al. A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population. Hypertension 52 (2008) 1142-1148